{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:21:07Z","timestamp":1769192467149,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10072-015-2113-5","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T11:45:31Z","timestamp":1424173531000},"page":"1501-1503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Paraneoplastic cerebellar degeneration with anti-CV2\/CRMP5 antibodies and prostate adenocarcinoma"],"prefix":"10.1007","volume":"36","author":[{"given":"A.","family":"Aliprandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Terruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bazzigaluppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tremolizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salmaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"2113_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.53.4.297","volume":"53","author":"T Klockgether","year":"1990","unstructured":"Klockgether T, Schroth G, Diener HC, Dichgans J (1990) Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry 53:297\u2013305","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2113_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2009.12.019","volume":"291","author":"JE Greenlee","year":"2010","unstructured":"Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG (2010) Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. J Neurol Sci 291:74\u201378","journal-title":"J Neurol Sci"},{"key":"2113_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(93)90176-Y","volume":"117","author":"JC Antoine","year":"1993","unstructured":"Antoine JC, Honnorat J, Vocanson C, Koenig F, Aguera M, Belin MF, Michel D (1993) Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina. J Neurol Sci 117:215\u2013223","journal-title":"J Neurol Sci"},{"key":"2113_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","volume":"80","author":"J Honnorat","year":"2009","unstructured":"Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, Chapuis F, Aguera M, Decullier E, Duchemin AM, Graus F, Antoine JC (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80:412\u2013416","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2113_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, Euronetwork PNS (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330\u2013335","journal-title":"Arch Neurol"},{"key":"2113_CR6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrurol.2010.186","volume":"7","author":"MK Hong","year":"2010","unstructured":"Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM, Costello AJ, Corcoran NM (2010) Paraneoplastic syndromes in prostate cancer. Nat Rev Urol 7:681\u2013692","journal-title":"Nat Rev Urol"},{"key":"2113_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurol.2009.04.009","volume":"166","author":"T Ritzenthaler","year":"2010","unstructured":"Ritzenthaler T, Verret JM, Honnorat J (2010) Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2\/CRMP5 antibodies and two different tumors. Rev Neurol (Paris) 166:90\u201395","journal-title":"Rev Neurol (Paris)"},{"key":"2113_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/030089160909500219","volume":"95","author":"M Simonelli","year":"2009","unstructured":"Simonelli M, Banna GL, Santoro A (2009) Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy. Tumori 95:243\u2013247","journal-title":"Tumori"},{"key":"2113_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/CRIAI:19:1:51","volume":"19","author":"V Rogemond","year":"2000","unstructured":"Rogemond V, Honnorat J (2000) Anti-CV2 autoantibodies and paraneoplastic neurological syndromes. Clin Rev Allergy Immunol 19:51\u201359","journal-title":"Clin Rev Allergy Immunol"},{"key":"2113_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1468-1331.2007.01802.x","volume":"14","author":"O Stich","year":"2007","unstructured":"Stich O, Rauer S (2007) Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2\/CRMP5 associated paraneoplastic neurological syndromes. Eur J Neurol 14:650\u2013653","journal-title":"Eur J Neurol"},{"key":"2113_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11060-009-0022-2","volume":"97","author":"E Saloustros","year":"2010","unstructured":"Saloustros E, Zaganas I, Mavridis M, Vamvakas L, Plaitakis A, Georgoulias V, Mavroudis D (2010) Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma. J Neurooncol 97:291\u2013294","journal-title":"J Neurooncol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-015-2113-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2113-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:30:06Z","timestamp":1566347406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-015-2113-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1007\/s10072-015-2113-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}